Improved assessment of laser-induced choroidal neovascularization.
The primary objective of this study was to develop and evaluate new methods of analyzing laser-induced choroidal neovascularization (CNV), in order to make recommendations for improving the reporting of experimental CNV in the literature. Six laser burns of sufficient power to rupture Bruch's membrane were concentrically placed in each eye of 18 adult Norway rats. Eyes received intravitreal injections of either triamcinolone acetonide, ketorolac, or balanced salt solution (BSS). Fluorescein angiography (FA) was performed 2 and 3 weeks after injection, followed by choroidal flat mount preparation. Vascular leakage on FAs and vascular budding on choroidal mounts were quantified by measuring either the cross-sectional area of each CNV lesion contained within the best-fitting polygon using Adobe Photoshop (Lasso Technique or Quick Selection Technique), or the area of bright pixels within a lesion using Image-Pro Plus. On choroidal mounts, the Lasso Technique and Image-Pro Plus detected a significant difference in lesion size between either ketorolac or triamcinolone when compared to BSS, while the Quick Selection Technique did not (Lasso Technique, 0.78 and 0.64; Image-Pro Plus, 0.77 and 0.65). On FA, the Lasso Technique and Quick Selection Technique detected a significant difference in lesion size between either ketorolac or triamcinolone when compared to BSS, while Image-Pro Plus did not (Lasso Tool, 0.81 and 0.54; Quick Selection Tool, 0.76 and 0.57). Choroidal mounts and FA are both valuable for imaging experimental CNV. Adobe Photoshop and Image-Pro Plus are both able to detect subtle differences in CNV lesion size, when images are not manipulated. The combination of choroidal mounts and FA provides a more comprehensive assessment of CNV anatomy and physiology.
Toma
Hassanain S
HS
Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Barnett
Joshua M
JM
Penn
John S
JS
Kim
Stephen J
SJ
D000818:Animals; D016570:Bruch Membrane / Q000098:blood supply*; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage; D004195:Disease Models, Animal; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000008:administration & dosage; D007090:Image Interpretation, Computer-Assisted; D058449:Intravitreal Injections; D020910:Ketorolac / Q000008:administration & dosage; D054020:Lasers, Gas; D008297:Male; D008856:Microscopy, Fluorescence; D051381:Rats; D011914:Rats, Inbred BN; D015203:Reproducibility of Results; D012984:Software; D013048:Specimen Handling; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000008:administration & dosage
D016861:Cyclooxygenase Inhibitors; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide; D020910:Ketorolac